Skip to main content
Livermore
Livermore
ZHEN

Structure Therapeutics Inc.

GPCR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001888886

No open-market purchases or sales by Structure Therapeutics Inc. insiders were filed in the last 90 days; 191 institutions reported holding it in 13F filings for Q2 2026, worth $3.62B in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Structure Therapeutics Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of GPCR: Q4 2023 compared with Q1 2024
MeasureQ4 2023Of which not filed for Q1 2024Q1 2024Change
Holders1221119−2
Shares42.7M5943.6M+965.5K (+2.3%)
Value$1.74B$2.40K$1.86B+$123.2M (+7.1%)

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Structure Therapeutics Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to GPCR in Q1 2024
InstitutionSharesValue% of portfolio
Money Concepts Capital Corp376,568$16.1M1.49%
American Century Companies Inc261,459$11.2M0.01%
Altitude Crest Partners Inc.205,166$8.79M3.76%
First Light Asset Management, LLC149,113$6.39M0.49%
Tang Capital Management LLC100,000$4.29M0.45%
Walleye Capital LLC93,794$4.02M0.04%
Caption Management, LLC70,000$3.00M0.33%
Macquarie Group Ltd58,000$2.49M0.00%
HAP Trading, LLC40,920$1.75M0.54%
Trexquant Investment LP29,941$1.28M0.03%
Nomura Asset Management Co Ltd17,777$761.9K0.00%
FORA Capital, LLC17,090$732.5K0.06%
Squarepoint Ops LLC13,832$592.8K0.00%
Silverarc Capital Management, LLC10,000$428.6K0.12%
NEOS Investment Management LLC9,949$426.4K0.03%
LPL Financial LLC8,794$376.9K0.00%
Cubist Systematic Strategies, LLC8,669$371.6K0.00%
Quadcap Wealth Management, LLC7,986$342.3K0.08%
Virtu Financial LLC7,186$308.0K0.02%
XTX Topco Ltd6,975$298.9K0.04%
Envestnet Asset Management Inc5,157$221.0K0.00%
Y-Intercept (Hong Kong) Ltd4,867$208.6K0.02%
Sivik Global Healthcare LLC4,464$191.0K0.07%
Jefferies Financial Group Inc.2,000$85.7K0.00%

Sold out (26)

Institutions that held Structure Therapeutics Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of GPCR in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Avoro Capital Advisors LLC2,333,333$95.1M
MPM Oncology Impact Management LP230,696$9.40M
Pictet Asset Management Holding SA138,797$5.66M
Victory Capital Management Inc125,447$5.11M
Bamco Inc118,333$4.82M
GMT Capital Corp81,700$3.33M
Exome Asset Management LLC68,100$2.78M
Weiss Multi-Strategy Advisers LLC48,914$1.99M
Parkman Healthcare Partners LLC38,678$1.58M
Engineers Gate Manager LP29,414$1.20M
E Fund Management Co., Ltd.28,589$1.17M
Kennedy Capital Management, Inc.25,876$1.05M
Twinbeech Capital LP24,290$990.1K
Group One Trading, L.P.17,914$730.2K
Ensign Peak Advisors, Inc16,300$664.4K
Ikarian Capital, LLC14,524$592.0K
Walleye Trading LLC13,879$565.7K
Prelude Capital Management, LLC13,700$558.4K
First Trust Advisors LP12,967$528.5K
Voya Investment Management LLC9,730$396.6K
Temasek Holdings (Private) Ltd9,617$392.0K
Schonfeld Strategic Advisors LLC9,200$375.0K
Raymond James & Associates5,705$232.5K
Picton Mahoney Asset Management2,410$98.0K
Steward Partners Investment Advisory, LLC679$27.7K
Able Wealth Management LLC14$571

Not filed for Q1 2024 yet (1)

Institutions that held Structure Therapeutics Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding GPCR in Q4 2023 that haven't filed for Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Fairfield Financial Advisors, LTD59$2.40K